Bonezzi, C;
Costantini, A;
Cruccu, G;
Fornasari, DMM;
Guardamagna, V;
Palmieri, V;
Polati, E;
... Dickenson, AH; + view all
(2020)
Capsaicin 8% dermal patch in clinical practice: an expert opinion.
Expert Opinion on Pharmacotherapy
10.1080/14656566.2020.1759550.
Preview |
Text
Capsaicin 8 dermal patch in clinical practice an expert opinion.pdf - Published Version Download (1MB) | Preview |
Abstract
Introduction: Neuropathic pain (NP) is caused by a lesion or disease of the somatosensory system, which can severely impact patients’ quality of life. The current-approved treatments for NP comprise of both centrally acting agents and topical drugs, including capsaicin 8% dermal patches, which is approved for the treatment of peripheral NP. / Areas covered: The authors summarize literature data regarding capsaicin use in patients who suffer from NP and discuss the clinical applications of this topical approach. / Expert opinion: Overall, the capsaicin 8% dermal patch is as effective in reducing pain intensity as other centrally active agents (i.e. pregabalin). Some studies have also reported fewer systemic side effects, a faster onset of action and superior treatment satisfaction compared with systemic agents. In our opinion, capsaicin 8% dermal patches also present additional advantages, such as a good systemic tolerability, the scarcity of adverse events, the possibility to combine it with other agents, and a good cost-effective profile. It is important to note that, as the mechanism of action of capsaicin 8% is the ‘defunctionalization’ of small afferent fibers through interaction with TRPV1 receptors, the peripheral expression of this receptor on nociceptor fibers, is crucial to predict patient’s response to treatment.
| Type: | Article |
|---|---|
| Title: | Capsaicin 8% dermal patch in clinical practice: an expert opinion |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1080/14656566.2020.1759550 |
| Publisher version: | https://doi.org/10.1080/14656566.2020.1759550 |
| Language: | English |
| Additional information: | Copyright © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
| Keywords: | Neuropathic pain, topical treatment, capsaicin, TRPV1 receptors, fibers |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Neuro, Physiology and Pharmacology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10106978 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
